Enanta Pharmaceuticals
ENTA
ENTA
105 hedge funds and large institutions have $139M invested in Enanta Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 109 → 105 (-4)
21% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 43
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Holders
105
Holding in Top 10
2
Calls
$409K
Puts
$9K
Top Buyers
| 1 | +$3.96M | |
| 2 | +$844K | |
| 3 | +$321K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$295K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$281K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$1.3M | |
| 3 | -$764K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$565K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$524K |
